You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

Welcome | My Account | E-mail Alerts | Access Rights | Sign In

Vol. 296 No. 1, July 5, 2006

JAMA
	•	Online Features

This Article
•	Abstract
•	Full text
•	Send to a friend
•	Save in My Folder
•	Save to citation manager
•	Permissions

Citing Articles
•	Contact me when this article is cited

Varenicline, an ${alpha}$ 4 $beta$ 2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial
JAMA Gonzales et al. 296 (1): 47.

Author in the Room

Author in the Room is an initiative from the Institute for Healthcare Improvement and JAMA to help facilitate the transition of science into practice. This Author in the Room conference took place on August 16, 2006.

Author in the Room Audio - July 5, 2006

Read the editorial by Drs DeAngelis and Berwick.

To register for future conferences, go to the IHI Web Site.

| | |